Ildong Pharmaceutical Company

Ildong Pharmaceutical Company company information, Employees & Contact Information

국민건강연구소 일동제약!

Company Details

Employees
154
Founded
-
Address
Yangjae-Dong, Seoul,seoul 06752,korea, Republic Of
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Seoul, Seoul
Looking for a particular Ildong Pharmaceutical Company employee's phone or email?

Ildong Pharmaceutical Company Questions

News

Ildong Pharm launches Ofev generic as Korea's ILD market competition heats up - koreabiomed.com

Ildong Pharm launches Ofev generic as Korea's ILD market competition heats up koreabiomed.com

Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease - ACS Publications

Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease ACS Publications

Ildong Pharmaceutical accelerates drug development for metabolic, autoimmune diseases - CHOSUNBIZ - Chosun Biz

Ildong Pharmaceutical accelerates drug development for metabolic, autoimmune diseases - CHOSUNBIZ Chosun Biz

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology - Business Wire

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology Business Wire

Ildong Pharmaceutical to refile approval application for oral Covid-19 treatment - koreabiomed.com

Ildong Pharmaceutical to refile approval application for oral Covid-19 treatment koreabiomed.com

Potential of Bifidobacterium lactis IDCC 4301 isolated from breast milk-fed infant feces as a probiotic and functional ingredient - Wiley Online Library

Potential of Bifidobacterium lactis IDCC 4301 isolated from breast milk-fed infant feces as a probiotic and functional ingredient Wiley Online Library

Ildong Pharma to spin off R&D subsidiary in Nov - The Korea Economic Daily Global Edition

Ildong Pharma to spin off R&D subsidiary in Nov The Korea Economic Daily Global Edition

Greater consumer awareness and more players could be key for boosting postbiotics growth – Ildong Bioscience - NutraIngredients.com

Greater consumer awareness and more players could be key for boosting postbiotics growth – Ildong Bioscience NutraIngredients.com

Ildong Confirms Higher Efficacy of Oral Obesity Drug Compared to Competitors - Businesskorea

Ildong Confirms Higher Efficacy of Oral Obesity Drug Compared to Competitors Businesskorea

Ildong Bioscience (CEO Ban Oh-hyun), an affiliate of Ildong Pharmaceutical Group, announced on the 2.. - 매일경제

Ildong Bioscience (CEO Ban Oh-hyun), an affiliate of Ildong Pharmaceutical Group, announced on the 2.. 매일경제

Discovery of μ,δ-Opioid Receptor Dual-Biased Agonists That Overcome the Limitation of Prior Biased Agonists - ACS Publications

Discovery of μ,δ-Opioid Receptor Dual-Biased Agonists That Overcome the Limitation of Prior Biased Agonists ACS Publications

Bifidobacterium lactis IDCC 4301 Exerts Anti-Obesity Effects in High-Fat Diet-Fed Mice Model by Regulating Lipid Metabolism - Wiley Online Library

Bifidobacterium lactis IDCC 4301 Exerts Anti-Obesity Effects in High-Fat Diet-Fed Mice Model by Regulating Lipid Metabolism Wiley Online Library

Ildong Pharmaceutical pill cuts weight up to 13.8% in 4 weeks in Korea trial - CHOSUNBIZ - Chosun Biz

Ildong Pharmaceutical pill cuts weight up to 13.8% in 4 weeks in Korea trial - CHOSUNBIZ Chosun Biz

Ildong’s oral GLP-1 drug shows up to 13.8% weight loss in phase 1 trial - koreabiomed.com

Ildong’s oral GLP-1 drug shows up to 13.8% weight loss in phase 1 trial koreabiomed.com

Cera-Glow, ferment lysates of Lacticaseibacillus rhamnosus IDCC 3201, improves skin barrier function in clinical study - Wiley Online Library

Cera-Glow, ferment lysates of Lacticaseibacillus rhamnosus IDCC 3201, improves skin barrier function in clinical study Wiley Online Library

Discovery of μ,δ-Opioid Receptor Dual-Biased Agonists That Overcome the Limitation of Prior Biased Agonists - ACS Publications

Discovery of μ,δ-Opioid Receptor Dual-Biased Agonists That Overcome the Limitation of Prior Biased Agonists ACS Publications

Ildong Pharmaceutical establishes new subsidiary to boost profitability, R&D - koreabiomed.com

Ildong Pharmaceutical establishes new subsidiary to boost profitability, R&D koreabiomed.com

Ildong wins Chinese and Japanese patent for GLP-1 new drug candidate - koreabiomed.com

Ildong wins Chinese and Japanese patent for GLP-1 new drug candidate koreabiomed.com

Ildong set to push releasing Covid-19 treatment Xocova to the end - koreabiomed.com

Ildong set to push releasing Covid-19 treatment Xocova to the end koreabiomed.com

Ildong releases antidiabetic DPP4+SGLT2 combo drug Qtern - koreabiomed.com

Ildong releases antidiabetic DPP4+SGLT2 combo drug Qtern koreabiomed.com

Ildong Pharmaceutical is launching Japan's "ROIHI-TSUBOKO," known as "Copper PAS," in Korea.Ildong P.. - 매일경제

Ildong Pharmaceutical is launching Japan's "ROIHI-TSUBOKO," known as "Copper PAS," in Korea.Ildong P.. 매일경제

Ildong Pharmaceutical develops its first new drug - koreabiomed.com

Ildong Pharmaceutical develops its first new drug koreabiomed.com

Ildong Foodis’ eating protein, “Himune”, emerges as a hit product - The Korea Post

Ildong Foodis’ eating protein, “Himune”, emerges as a hit product The Korea Post

Therapeutic effect of tyndallized Lactobacillus rhamnosus IDCC 3201 on atopic dermatitis mediated by down-regulation of immunoglobulin E in NC/Nga mice - Wiley Online Library

Therapeutic effect of tyndallized Lactobacillus rhamnosus IDCC 3201 on atopic dermatitis mediated by down-regulation of immunoglobulin E in NC/Nga mice Wiley Online Library

Hanyang Securities predicts Ildong to transfer oral obesity drug soon - CHOSUNBIZ - Chosun Biz

Hanyang Securities predicts Ildong to transfer oral obesity drug soon - CHOSUNBIZ Chosun Biz

Ildong Pharmaceutical (CEO Yoon Woong-seop) announced on the 17th that it will launch the oral hemor.. - 매일경제

Ildong Pharmaceutical (CEO Yoon Woong-seop) announced on the 17th that it will launch the oral hemor.. 매일경제

Top Ildong Pharmaceutical Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant